If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Directorate Change

9 Feb 2011 11:15

RNS Number : 9398A
Consort Medical PLC
09 February 2011
 



 

 

 

News Release

 

9 February 2011

 

 

Consort Medical plc

 

Consort Medical announces the appointment of Dr. Lynn Drummond to the Board

 

Consort Medical plc ("Consort") is pleased to announce the appointment of Dr. Lynn Drummond as a Board member, effective today.

 

Dr. Drummond has a strong track record within the life sciences sector, bringing over twenty years of management and advisory experience. Lynn spent 16 years at Rothschild in London most recently as a Managing Director within the investment banking division, with a particular focus on transactions within the healthcare sector. Prior to this she worked in the Cabinet Office in London as Private Secretary to the Chief Scientific Advisor. Lynn is also a non executive director of Alimentary Health in Ireland.

 

Dr. Drummond holds a Bachelor of Science Degree in Chemistry from the University of Glasgow and a PhD in Biochemistry from the University of London. She is also a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Edinburgh.

 

Commenting on Dr. Drummond's appointment, Peter Fellner, Chairman said:

"We are delighted that Lynn is joining Consort as a Board member. Lynn brings a tremendous set of skills and experience to the Board and we look forward to working with her."

 

Dr. Lynn Drummond commented:

"Consort has an established reputation as a leader in pharmaceutical drug delivery systems and I look forward to being a part of this growing business and working with the Board to deliver value for shareholders."

 

 

END

 

Enquiries

Consort Medical plc

Tel: +44 (0) 1442 867920

Jonathan Glenn, Chief Executive Officer

Toby Woolrych, Group Finance Director

Brunswick

Tel: +44 (0) 20 7404 5959

Jon Coles/Justine McIlroy

 

Consort Medical plc is a leader in medical devices for drug delivery and device technologies. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.

 

Consort Medical develops and manufactures metered dose inhaler valves, autoinjectors, needle free injectors, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits, video laryngoscopes and laryngeal tubes. The Group has a Head Office in Hemel Hempstead, UK and manufacturing facilities in King's Lynn, Norfolk, and Nelson, Lancashire in the UK, Indianapolis, Indiana and Kent, Ohio in the US. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGGZMLDGMZM
Date   Source Headline
1st Nov 20179:35 amRNSDirector/PDMR Shareholding
1st Nov 20179:04 amRNSTotal Voting Rights
16th Oct 20179:42 amRNSBlock listing Interim Review
11th Oct 20172:10 pmRNSDirector/PDMR Shareholding
11th Oct 201711:38 amRNSHolding(s) in Company
2nd Oct 201710:03 amRNSTotal Voting Rights
11th Sep 20175:15 pmRNSDirector/PDMR Shareholding
7th Sep 20171:56 pmRNSDirector/PDMR Shareholding
6th Sep 20174:35 pmRNSResult of AGM
1st Sep 20172:47 pmRNSDirector Declaration
10th Aug 20178:38 amRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
28th Jul 20173:48 pmRNSPosting of Annual Financial Report and AGM Notice
26th Jul 20179:22 amRNSDirector/PDMR Shareholding
20th Jul 20178:07 amRNSAdditional Listing
11th Jul 20178:53 amRNSDirector/PDMR Shareholding
21st Jun 201712:10 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
21st Jun 201712:09 pmRNSDirector/PDMR Shareholding
15th Jun 20177:00 amRNSFull year results
5th Jun 201710:09 amRNSDirector Declaration
8th May 20177:00 amRNSNotice of Results
2nd May 201711:10 amRNSTotal Voting Rights
27th Apr 201711:51 amRNSResult of General Meeting
18th Apr 20179:36 amRNSBlock listing Interim Review
3rd Apr 20179:49 amRNSNotice of GM
1st Mar 20179:22 amRNSTotal Voting Rights
30th Jan 201712:44 pmRNSHolding(s) in Company
26th Jan 20172:59 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSParticipation in equity raise for Atlas Genetics
3rd Jan 20177:00 amRNSVoke® (DEV200) update
15th Dec 20169:45 amRNSHolding(s) in Company
14th Dec 201610:35 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSDirectorate Change
9th Dec 20163:18 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSInterim Results
2nd Dec 20169:25 amRNSHolding(s) in Company
1st Dec 20169:43 amRNSTotal Voting Rights
25th Nov 20167:00 amRNSCFO Appointment
8th Nov 20161:24 pmRNSDirector/PDMR Shareholding
1st Nov 201610:15 amRNSTotal Voting Rights
31st Oct 20163:32 pmRNSDirector/PDMR Shareholding
31st Oct 20161:00 pmRNSNotice of Results
27th Oct 20167:00 amRNSCIMZIA® AutoClicks® prefilled pen launched in UK
14th Oct 201610:02 amRNSBlock listing Interim Review
14th Oct 20167:00 amRNSAnnouncement of master development agreement
11th Oct 201612:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20169:00 amRNSTotal Voting Rights
19th Sep 20169:47 amRNSBespak Technology in UCB PrefilledPen EMA Approval

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.